📰 Safety Analyses News
Safety Analyses News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Safety Analyses. Real-time updates on events, politics, business and more.
October 16, 2023
– Real-World Evidence and New Clinical Analysis Support the Role of Trodelvy® in Metastatic Breast Cancers – – New Data Demonstrate Potential of Trodelvy in Small Cell Lung Cancer,...
September 8, 2022
Since its inception, a professional performing the job of an Industrial Hygienist (“IH”) has been dedicated to ensuring the health and well-being of the worker. Over the years, this...
June 1, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with...
June 4, 2021
NEW YORK, NY / ACCESSWIRE / June 4, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
June 3, 2021
NEW YORK, NY / ACCESSWIRE / June 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.
June 3, 2021
NEW YORK, NY / ACCESSWIRE / June 3, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
May 26, 2021
NEW YORK, NY / ACCESSWIRE / May 26, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.
May 20, 2021
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired FibroGen Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) securities and/or sold put options between October 18, 2017 and April 6, 2021 inclusive (the "Class Period"). FibroGen investors have until June 11, 2021 file a lead plaintiff motion.